Copper metabolism identified as a new therapeutic target for inflammatory osteolysis

https://www.news-medical.net/news/20260305/Copper-metabolism-identified-as-a-new-therapeutic-target-for-inflammatory-osteolysis.aspx Inflammatory osteolysis is a condition involving progressive bone tissue destruction and is observed in many well-known skeletal disorders, including rheumatoid arthritis, osteoporosis, and chronic apical periodontitis. This condition is driven by immune hyperactivation, sustained immune responses, and increased numbers of bone-degrading osteoclast cells, which together cause inflammation and weakening of affected bone tissue.